Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy

While modified FOLFIRINOX therapy is effective for treating advanced pancreatic cancer, it frequently causes severe neutropenia. The present study investigated the effect of severe neutropenia on clinical outcomes in advanced pancreatic cancer patients who received modified FOLFIRINOX. The study sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yunami, Fujii, Hironori, Watanabe, Daichi, Kato-Hayashi, Hiroko, Ohata, Koichi, Kobayashi, Ryo, Ishihara, Takuma, Uemura, Shinya, Iwashita, Takuji, Shimizu, Masahito, Suzuki, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265962/
https://www.ncbi.nlm.nih.gov/pubmed/30453583
http://dx.doi.org/10.3390/cancers10110454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265962/
https://www.ncbi.nlm.nih.gov/pubmed/30453583
http://dx.doi.org/10.3390/cancers10110454

Ejemplares similares